Voyager Therapeutics, Inc. (VYGR) SEC filings
Every SEC filing by Voyager Therapeutics, Inc. (CIK 0001640266) in the last two years, with each form explained in plain English and links to the SEC's copies. Industry: Biological Products, (No Diagnostic Substances). VYGR stock report · earnings · news
Annual & quarterly reports
- 2026-11-05 · 10-Q Quarterly report · document
- 2026-08-06 · 10-Q Quarterly report · document
- 2026-05-07 · 10-Q Quarterly report · document
- 2026-03-09 · 10-K Annual report · document
- 2025-11-10 · 10-Q Quarterly report · document
- 2025-08-06 · 10-Q Quarterly report · document
- 2025-05-06 · 10-Q Quarterly report · document
- 2025-03-11 · 10-K Annual report · document
Major events
- 2026-11-18 · 8-K/A Earnings results · document
- 2026-11-05 · 8-K Acquisition or sale completed · document
- 2026-10-21 · 8-K Executive or director change · document
- 2026-08-06 · 8-K Earnings results · document
- 2026-07-13 · 8-K Other event · document
- 2026-06-10 · 8-K Bylaw or charter change · Shareholder vote results · document
- 2026-06-01 · 8-K Other event · document
- 2026-05-07 · 8-K Earnings results · document
- 2026-04-21 · 8-K Executive or director change · document
- 2026-03-09 · 8-K Earnings results · document
- 2026-02-12 · 8-K Executive or director change · Other event · document
- 2026-01-08 · 8-K Regulation FD disclosure · document
- 2025-11-10 · 8-K Earnings results · document
- 2025-09-02 · 8-K Regulation FD disclosure · document
- 2025-08-06 · 8-K Earnings results · document
- 2025-06-05 · 8-K Executive or director change · Shareholder vote results · document
- 2025-05-06 · 8-K Earnings results · document
- 2025-03-11 · 8-K Earnings results · document
- 2025-02-11 · 8-K Other event · document
Big shareholders
- 2026-11-16 · SCHEDULE 13G Over 5% stake, passive investor · document
- 2026-11-16 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2026-08-14 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2026-07-31 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2026-05-15 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2026-05-15 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2026-03-27 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2026-02-18 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2026-02-17 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2026-01-26 · SCHEDULE 13G Over 5% stake, passive investor · document
- 2025-11-14 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2025-11-14 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2025-08-14 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2025-05-15 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2025-04-24 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2025-02-14 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
Proxy & votes
- 2026-04-28 · DEFA14A Additional proxy material · document
- 2026-04-28 · DEF 14A Proxy statement (annual meeting, pay, votes) · document
- 2026-04-10 · PRE 14A Preliminary proxy statement · document
- 2025-04-23 · DEFA14A Additional proxy material · document
- 2025-04-23 · DEF 14A Proxy statement (annual meeting, pay, votes) · document
Offerings & registrations
- 2025-12-01 · EFFECT Registration takes effect · document
- 2025-12-01 · 424B3 Prospectus · document
- 2025-11-10 · S-3 Shelf registration · document
- 2025-06-09 · S-8 Employee stock plan registration · document
- 2025-03-11 · S-8 Employee stock plan registration · document
85 insider filings (Forms 3, 4, 5 and 144) in the same period.
Filings link to sec.gov. Research data, not investment advice. Latest SEC filings